Changes in levels of neuromarkers and cognitive functioning of patients with treatment-resistant schizophrenia

Changes in levels of neuromarkers and cognitive functioning of patients with treatment-resistant schizophrenia

In this paper we analyze the changes in the blood levels of neuron-specific enolase and S100B protein during combined ECT and pharmacological treatment in patients suffering from treatment-resistant paranoid schizophrenia. Correlations between biomarkers’ serum levels, clinical status and characteri...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. . Zubov, M. . Dorofeikova, N. . Petrova, V. . Dorofeykov, M. . Ivanov
Format:	Article
Language:	Russian
Published:	Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2018-07-01
Series:	Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:	шизофрения электросудорожная терапия нейромаркеры когнитивное функционирование schizophrenia electroconvulsive therapy biomarkers cognitive functioning
Online Access:	https://www.bekhterevreview.com/jour/article/view/30
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Changes in levels of neuromarkers and cognitive functioning of patients with treatment-resistant schizophrenia
by: M. . Dorofeykova
Published: (2018-07-01)

Combined use of antipsychotics and electroconvulsive therapy in theurapetically resistant schizophrenia
by: S. V. Sizov, et al.
Published: (2018-07-01)

The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function
by: Ying Yang, et al.

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023-07-01)

Oculomotor response as cognitive deficit marker in affective and anxiety spectrum disorders
by: I. G. Shalaginova, et al.
Published: (2018-07-01)

Effects of modifying the pulse width on cognitive side effects with electroconvulsive therapy for schizophrenia
by: Qi Si, et al.
Published: (2025-09-01)

Comparative analysis of psychological adaptation in patients with paranoid schizophrenia and shizotypal disorder
by: A. V. Stepanova
Published: (2015-03-01)

Psychoeducation: Issues and Directions for Research
by: N. D. Semenova, et al.
Published: (2018-07-01)

Lorazepam provocation test in purported schizophrenia with lack of treatment response
by: John E. Berg
Published: (2014-09-01)

Variants of cognitive deficiency depending on the clinical characteristics of the disease in patients with paranoid schizophrenia
by: G. G. Lebedeva, et al.
Published: (2015-03-01)

Study protocol of a German multi-center, observer-blind, randomized, and actively controlled parallel-group trial comparing maintenance electroconvulsive therapy to treatment as usual for relapse prevention in clozapine resistant schizophrenia
by: Anton Deicher, et al.
Published: (2025-05-01)

Patient social function and quality of life in schizophrenia: focus on paliperidone palmitate
by: E. V. Grigorieva
Published: (2018-07-01)

Efficacy of modified electroconvulsive therapy combined with medication in inpatient schizophrenia patients and urban-rural differences
by: Xie Hongcheng, et al.
Published: (2024-12-01)

Comparative evaluation of psychopharmacotherapy inpatients with the first-episode psychosis
by: N. N. Petrova, et al.
Published: (2015-09-01)

The diagnostic potential of unconjugated bilirubin in schizophrenia and bipolar disorder
by: Huang-Hui Liu, et al.
Published: (2025-07-01)

Copings and self-regulation of behavior in patients with schizophrenia and affective disorders
by: V. Yu. Kudryashova, et al.
Published: (2018-07-01)

Association between mechanisms of psychological adaptation and cognitive functioning violation in patients with schizotypal disorder
by: A. V. Stepanova, et al.
Published: (2018-07-01)

Electroconvulsive therapy for an older patient with schizophrenia complicated by nonconvulsive status epilepticus during catatonia: A case report
by: Ayumi Takeshita, et al.
Published: (2025-06-01)

Adverse effects of electroconvulsive therapy on cognitive performance
by: Sasha S. Getty, et al.
Published: (2017-10-01)

The correlation between psychosocial characteristics and psychiatric hospital admission rates of patients with paranoid schizophrenia
by: V. E. Pashkovskiy, et al.
Published: (2018-07-01)

Cognitive function changes during a course of electroconvulsive therapy in patients with various psychiatric illnesses: A prospective observational study
by: Harita Patel, et al.
Published: (2025-05-01)

Effects of electroconvulsive therapy on serum brain derived neurotrophic factor, serum interleukin-6, and serum cortisol levels in patients with treatment refractory schizophrenia
by: Nikhil Gurjar, et al.
Published: (2025-01-01)

Monitoring of clozapine and norclozapine concentrations in schizophrenia treatment
by: N. V. Baymeeva, et al.
Published: (2018-02-01)

Molecular physiology unlocks the mystery that relates cognitive impairment with the retina in schizophrenia and autism spectrum disorders: a perspective review
by: Sarah Al-Mazidi, et al.
Published: (2024-11-01)

Assessment of the German Version of Brief Assessment of Cognition in Schizophrenia (BACS)
by: Matin Mortazavi, et al.
Published: (2025-09-01)

Association between treatment resistance and cognitive function in schizophrenia
by: Jiaqian Sun, et al.
Published: (2024-10-01)

Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS)
by: Xiang Q, et al.
Published: (2025-03-01)

Modern dilemma in the therapy of the schizophrenia: neurocognition and social cognition
by: N. B. Lutova, et al.
Published: (2019-10-01)

ECT-induced primary open-angle glaucoma in a patient with unstable thyroid function: a case report
by: Cuiyuan Fu, et al.
Published: (2025-03-01)

A Case Report of Schizophrenia with Impaired Social Cognition
by: Faton Kutllovci, et al.
Published: (2025-06-01)

Thalamocortical white matter connectivity and the entorhinal cortex as neural correlates of electroconvulsive therapy response in patients with schizophrenia spectrum disorder
by: Minah Kim, et al.
Published: (2025-07-01)

Fine-tuning electroconvulsive therapy: A cognitive comparison of brief and ultra-brief pulse widths
by: Vishesh Yadav, et al.
Published: (2025-07-01)

Efficacy of Adjuvant Yoga Therapy for Cognition in Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials
by: Daiveek G. Pattanashetty, et al.
Published: (2025-01-01)

Cognitive impairments in schizophrenia and their impact on oxidative stress
by: A. S. Piatoikina, et al.
Published: (2022-10-01)

Dysregulation of MiRNAs in schizophrenia in an Egyptian patient population
by: Nabila M. Adly, et al.
Published: (2025-05-01)

Neurocognitive impairments in patients with schizophrenia and schizophrenia spectrum disorders: cluster analysis results
by: M. V. Karyakina, et al.
Published: (2020-04-01)

"Pathologic foresight" syndrome and its place in the onset of paranoid schizophrenia
by: S. V. Litvintsev
Published: (2018-07-01)

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
by: Wang LJ, et al.
Published: (2016-10-01)

Social cognition in schizophrenia
by: Thammanard Charernboon, et al.
Published: (2017-03-01)

The NCAN gene: schizophrenia susceptibility and cognitive dysfunction
by: Wang P, et al.
Published: (2016-11-01)